| EXAS |
Exact Sciences Corp |
92%
|
Reciprocal relationship from EXAS graph: Exact entered into an Agreement and Plan of Merger, dated as of November 19, 2025 (the “ Merger Agreement ”), with Abbott Laboratories, an Illinois corporatio… |
| ENTA |
Enanta Pharmaceuticals, Inc. |
90%
|
Reciprocal relationship from ENTA graph: We entered into a Collaborative Development and License Agreement with Abbott Laboratories in November 2006 to develop and commercialize HCV NS3 and NS3/4A pr… |
| GRAL |
GRAIL, Inc. |
85%
|
Reciprocal relationship from GRAL graph: Exact Sciences Corporation (recently announced to be acquired by Abbott Laboratories) |
| ALVO |
Alvotech |
72%
|
Reciprocal relationship from ALVO graph: ion, variation or revocation of an approval. As a result, our business, financial condition and results of operations may be materially harmed. Additionally, … |
| AORT |
Artivion, Inc. |
72%
|
Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a re… |
| CODX |
Co-Diagnostics, Inc. |
72%
|
Reciprocal relationship from CODX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CODX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CODX gra… |
| CVRX |
CVRx, Inc. |
72%
|
Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific C… |
| DXCM |
DexCom, Inc. |
72%
|
Reciprocal relationship from DXCM graph: we have not built a sales force. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several internati… |
| FLGT |
Fulgent Genetics, Inc. |
72%
|
Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair serv… |
| GCTK |
GlucoTrack, Inc. |
72%
|
Reciprocal relationship from GCTK graph: Reciprocal relationship from ABT graph: Reciprocal relationship from GCTK graph: ability to commercialize our products. 12 The Privacy Provisions of HIPAA In … |
| GIFLF |
Grifols, S.A. |
72%
|
Reciprocal relationship from GIFLF graph: ither in late 2025 or early 2026 depending on approvals from regulatory authorities. In several countries, we distribute BLOODchip ® blood group genotyping t… |
| HAE |
Haemonetics Corporation |
72%
|
Reciprocal relationship from HAE graph: gies (“Terumo BCT”) and Fresenius SE & Co. KGaA, in particular, have significant financial and other resources and are strong competitors in a number of our bu… |
| IDXX |
IDEXX Laboratories, Inc. |
72%
|
Reciprocal relationship from IDXX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IDXX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IDXX gra… |
| IINN |
Inspira Technologies Oxy B.H.N. Ltd. |
72%
|
Reciprocal relationship from IINN graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IINN graph: Reciprocal relationship from ABT graph: Reciprocal relationship from IINN gra… |
| ITGR |
Integer Holdings Corporation |
72%
|
Reciprocal relationship from ITGR graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ITGR graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ITGR gra… |
| IVA |
Inventiva S.A. |
72%
|
Reciprocal relationship from IVA graph: anor. In addition, certain of the completed clinical trials for lanifibranor were conducted in patients with type 2 diabetes, or T2D, which is a different indi… |
| MMM |
3M Company |
72%
|
Reciprocal relationship from MMM graph: d Chief Executive Officer, L3Harris Technologies, 2019-2021 Anurag Maheshwari 52 Executive Vice President, Chief Financial Officer 2024 Executive Vice Presiden… |
| MMSI |
Merit Medical Systems, Inc. |
72%
|
Reciprocal relationship from MMSI graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MMSI graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MMSI gra… |
| MOVE |
Corvex Inc. |
72%
|
Reciprocal relationship from MOVE graph: n’s (“E.U.”) General Data Protection Regulation (“GDPR”). The GDPR and other national or provincial laws provide a prescriptive, detailed regulation that prov… |
| MTLS |
Materialise NV |
72%
|
Reciprocal relationship from MTLS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MTLS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from MTLS gra… |
| NBP |
NovaBridge Biosciences |
72%
|
Reciprocal relationship from NBP graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NBP graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NBP graph:… |
| NSPR |
InspireMD, Inc. |
72%
|
Reciprocal relationship from NSPR graph: fficiently or implement changes in current products in response to design or regulatory requirements; and ● difficulty identifying and qualifying, and obtaini… |
| NSTS |
NSTS Bancorp, Inc. |
72%
|
Reciprocal relationship from NSTS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NSTS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from NSTS gra… |
| NVEC |
NVE Corporation |
72%
|
Reciprocal relationship from NVEC graph: ch 31, 2025, we had more than 50 issued U.S. patents assigned to us. We also have a number of foreign patents, several U.S. and foreign patents pending, and w… |
| NVS |
Novartis AG |
72%
|
Reciprocal relationship from NVS graph: Switzerland (1993–2022) • Senior partner and Board chair, Bär & Karrer AG, Switzerland (2011–2021) • Lawyer, District Court of Affoltern, Court of Appeals/Cour… |
| OBIO |
Orchestra BioMed Holdings, Inc. |
72%
|
Reciprocal relationship from OBIO graph: Reciprocal relationship from ABT graph: Reciprocal relationship from OBIO graph: ve interventional cardiology field include Boston Scientific Corporation, Med… |
| ONCO |
Onconetix, Inc. |
72%
|
Reciprocal relationship from ONCO graph: Reciprocal relationship from ABT graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and … |
| PLSE |
Pulse Biosciences, Inc. |
72%
|
Reciprocal relationship from PLSE graph: Reciprocal relationship from ABT graph: Reciprocal relationship from PLSE graph: ucted by Professor Stefano Spiezia at the Ospedale del Mare in Naples, Italy,… |
| PSNL |
Personalis, Inc. |
72%
|
Reciprocal relationship from PSNL graph: ogy therapies approved by the FDA along with companion diagnostics increases. For example, the FDA has approved several such targeted oncology therapies that … |
| QDEL |
QuidelOrtho Corporation |
72%
|
Reciprocal relationship from QDEL graph: Reciprocal relationship from ABT graph: Reciprocal relationship from QDEL graph: s. Some of our principal competitors include, among others, Abbott Laboratori… |
